Chloracetanilide herbicides are multisite carcinogens in rodents. Progression of alachlor-induced olfactory tumors in rats is accompanied by cytoplasmic accumulation and nuclear localization of β-catenin, suggesting activation of Wnt signaling. Female CD-1 mice were resistant to alachlorinduced olfactory carcinogenesis. The current studies were performed to determine whether Apc Min/+ mice, which have activated Wnt signaling due to mutation of the second allele of Apc, would be susceptible to alachlor olfactory carcinogenesis. Female and male Apc Min/+ mice, as well as Apc +/+ littermates received alachlor in the diet (260 mg/kg/d) for up to 3 months. Female A/J and C57BL/6J wild-type mice were also treated (for 10 and 14 months, respectively), as these strains vary in sensitivity to many respiratory tract insults. No olfactory mucosal tumors were observed in any of the mice, although alachlor-treated Apc Min/+ mice developed histological changes similar to those in alachlor-treated rats. Alachlor-treated A/J mice developed pronounced intracellular accumulation of amorphous eosinophilic material in the olfactory mucosa, foci of respiratory-like metaplasia, and hyperplasia of nasal mucus glands. A similar but less intense response was seen in C57BL/6J mice. Mice and rats had equivalent levels of the putative bioactivating enzyme (CYP2A) in olfactory mucosa, and mice had induced hepatic CYP3A and CYP2B enzymes with alachlor treatment, which may increase alachlor elimination. These studies extend previous observations by describing alachlor-induced olfactory mucosal changes in mice and suggest that hepatic metabolic enzyme induction may be responsible for resistance of mice to alachlor-induced olfactory carcinogenesis.
INTRODUCTION
Alachlor (2-chloro-2 ,6-diethyl-N -(methoxymethyl)-acetanilide) is one of several chloracetanilide herbicides that are widely used in the production of many important crops, including corn, soybeans, and rice. These compounds differ in their toxicological endpoints, with various members of this class (others include acetochlor, metolachlor, butachlor and propachlor) causing nasal, thyroid, stomach, and/or liver tumors in rats (U.S. EPA, 1998) . A chronic feeding study to determine the time course and mechanism of alachlor-induced nasal carcinogenesis found that alachlor-induced nasal tumors originate from the ethmoid turbinates and are first detected following 5 months of exposure at 126 mg/kg/d, a dose used in previous chronic studies (U.S. EPA, 1985; Genter et al., 2002a) . Fifty percent of treated rats developed 1 or more nasal tumors following 6 months of exposure. The incidence increased to >95% following 1 year of exposure, with multiple neoplasms per tumor bearing rat. Following 18 months of exposure, one or more neoplasms is present in 100% of treated rats. (Genter et al., 2000 (Genter et al., , 2002a . The progression from adenoma to adenocarcinoma was associated with upregulation of Axin2 and accumulation of β-catenin in the nuclei of tumor cells, suggesting activation of the Wnt signaling pathway (Genter et al., 2002b) .
Alachlor is also associated with lung carcinogenesis, but not olfactory tumors, in female CD-1 mice (dosed for 2 years at 260 mg/kg/d; U.S. EPA, 1985) . To our knowledge, no other strain of mouse has been tested for this endpoint. Further, there have been few studies to characterize the interspecies difference in response, which is an important consideration, given that rat olfactory tumors are currently the basis for EPA's risk assessment for alachlor (U.S. EPA, 1985 EPA, , 1998 .
Therefore, we designed the present studies to ask 2 questions. First, are Apc Min/+ mice, which form intestinal tumors characterized by activated Wnt signaling (Su et al., 1992) , susceptible to alachlor-induced olfactory mucosal carcinogenesis? The Apc tumor suppressor is normally capable of downregulating Wnt signaling by facilitation of β-catenin destruction (Kawahara et al., 2000) . Second, we wanted to know whether resistance to alachlor-induced olfactory carcinogenesis is common to multiple mouse strains. Therefore, we also treated 2 inbred strains of mice commonly used in respiratory toxicology studies, namely A/J and C57BL/6J mice, which are sensitive (A/J) or resistant (C57BL/6J) to many respiratory tract irritants and carcinogens (Prows and Leikauf, 2001; Wang et al., 2004) . None of the strains tested developed alachlor-induced tumors. However, olfactory mucosal lesions related to alachlor exposure were present and included abnormal morphology of the olfactory mucosa, accumulation of eosinophilic material, and loss of olfactory marker protein (OMP) immunoreactivity, which is a marker for mature olfactory neurons (Kream and Margolis, 1984) . 720 GENTER ET AL. TOXICOLOGIC PATHOLOGY METHODS Female A/J and C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor ME). Male and female Apc Min/+ mice (on C57BL/6J background) and their age-matched, wild-type littermates were obtained from an in-house breeding colony originally established from mice obtained from The Jackson Laboratory. The experimental design was based on that previously described (U.S. EPA, 1998) . Briefly, control and alachlor-treated mice were housed 4/cage in the same room in filter-topped cages and administered alachlor (Chem Services, West Chester, PA, USA; >98% purity; 260 mg/kg/day) in powdered LM-485 rodent chow (Harlan/Teklad, Indianapolis, IN, USA). Alachlor content was adjusted weekly based on body weight gain and food consumption. Control mice received powdered diet only. Tap water was available ad libitum. For A/J and C57BL/6J mice, 12 mice were treated and 4 were untreated; for Apc Min/+ and Apc Min+/+ mice, 11 animals were in each group. Due to the short life expectancy of Apc Min/+ mice (approximately 5 months) and A/J mice (approximately 1 year (Tillmann et al., 2000) ), exposures were of shorter duration than classical 2-year bioassays. Apc Min/+ mice and their age-matched Apc +/+ littermates received 2-3 months of alachlor exposure, and A/J mice received 10.5 months of treatment. C57BL/6J mice were treated for 14 months. Studies were approved by the University of Cincinnati Institutional Animal Care and Use Committee.
Alachlor-treated mice and the respective controls were sacrificed using carbon dioxide, and tissues were prepared as previously described (Genter et al., 2000) . Nasal cavities were decalcified in 10% formic acid for approximately 5 days. Transverse sections were taken through the ethmoid turbinates, corresponding approximately to nasal cavity levels 3 and 4 (Young, 1981) . Random intestinal sections and thyroids were embedded in paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin or Wright-Giemsa prior to microscopic evaluation. Intestinal and thyroid sections were examined in order to determine whether alachlor had any effect on intestinal tumor histology grade in Apc Min/+ mice and to determine whether histological changes similar to those seen in rat thyroids (U.S. EPA, 1985 EPA, , 1998 developed in mice.
Immunohistochemistry (IHC) was performed on serial paraffin embedded sections using antibodies detailed in Table 1 . Primary antibodies were applied overnight at 4 • C, and secondary antibodies were applied (1:100) for 45 min- utes at room temperature. Distribution of antibody reactivity was detected using TSA enhancement (Perkin Elmer) and aminoethylcarbazole (AEC) as chromagen (Genter et al., 2002b) . Western blot analysis allowed comparison of CYP2A protein levels in C57BL/6J mouse and Long Evans rat olfactory mucosa and also provided data to determine whether alachlor treatment induced enzymes involved in metabolism of chloracetanilide herbicides in the mouse liver (Coleman et al., 1999 (Coleman et al., , 2000 . Olfactory mucosal S9 fractions were prepared by homogenization of ethmoid turbinates (from 1 Long-Evans rat or 4 C57BL/6J mice per preparation) in microsome buffer (50 mM potassium phosphate, 1.15% KCl, 0.1 mM EDTA, pH 7.4) and centrifugation at 9,000 × g. Livers (∼5 g/mouse) were homogenized and centrifuged at 9,000 × g, and the resulting supernatant was centrifuged at 100,000 × g for microsome preparations. Microsomes were resuspended in microsome buffer. Protein concentration of the supernatant was determined using Bradford reagent (Biorad, Hercules, CA). Proteins were separated on 10% reducing SDS polyacrylamide gels, and transferred to nitrocellulose. Equivalent protein loading and quality of transfer were assessed using Ponceau S (Sigma-Aldrich). Blots were sequentially probed with the antibodies detailed in Table 1 . Enhanced chemiluminescent (ECL) reagent was obtained from Amersham Biosciences. Membranes were stripped for reprobing by heating to 50 • C for 1 hour in 62.5 mM Tris, pH 6.8 containing 2% SDS (w/v), and 0.7%
RESULTS
The olfactory mucosa of untreated Apc Min/+ mice was not histologically different than that of other strains of mice previously examined. In most of the alachlor-treated Apc Min/+ mice, no histological changes in the olfactory mucosa were observed. A subset of the alachlor-treated Apc Min/+ and C57BL/6J littermates displayed changes similar to those observed in alachlor-treated rats that go on to develop olfactory mucosal tumors. These changes included hyperplasia of Bowman's glands, cells migrating horizontally across the surface of the olfactory epithelium, and hypercellularity of the epithelium (Figure 1) .
The olfactory mucosa of untreated A/J and C57BL/6J mice appeared completely normal. The olfactory mucosa of all A/J mice treated with alachlor for 10.5 months, and most of the C57BL/6J mice treated for 14 months, displayed mucous Vol. 32, No. 6, 2004 MURINE OLFACTORY RESPONSES TO ALACHLOR 721 gland hyperplasia and massive intracellular accumulation of an eosinophilic material ( Figure 1 ). Such accumulations of eosinophilic material have previously been reported in response to advanced age and inhaled compounds (Buckley et al., 1985; Wolf et al., 1995; Genter and Ali, 1998) , but not as a consequence of systemically administered compounds. These observations are consistent with previous findings that mice appear to be resistant to the olfactory mucosal carcinogenicity of alachlor (U.S. EPA, 1985) , and extend previous observations to demonstrate that alachlor-related histological changes can develop.
Examination of other tissues in treated and untreated mice showed that the intestinal tumors in Apc Min/+ mice treated with alachlor were indistinguishable from those of untreated, age-matched Apc Min/+ mice. There were no histological lesions in the thyroids from any of the treated mice. Lungs from the wild type C57BL/6J mice were examined for lung tumor formation, but none were noted, suggesting that the lung tumors previously noted in alachlor-treated mice (U.S. EPA, 1985) developed with considerably longer exposure. Respiratory mucosa of A/J and C57BL/6J mice treated with alachlor displayed similar eosinophilic accumulation as the olfactory mucosa, but to a much lesser extent.
Western blot analysis revealed no differences in the levels of CYP2A in the olfactory mucosa of rats and mice ( Figure 2 ). While CYP2A5 is increased in the liver by some agents such as pyridine, phenobarbital, and oxidative stress FIGURE 2.-Western blot analysis of enzymes relevant to alachlor metabolism. The samples evaluated (10 µg/lane) were Long-Evans rat and C57BL/6J mouse olfactory mucosal S9 fractions (ROE and MOE, respectively), and liver microsomes from control C57BL/6J (CL1, CL2) or alachlor-treated (260 mg/kg/d × 14 months) mice (AL1, AL2). Mouse and rat have equivalent amounts of CYP2A, proposed to be important in alachlor bioactivation, in olfactory mucosa. CYP3A and 2B enzymes catalyze early steps in the metabolism of multiple chloracetanilide compounds (Coleman et al., 1999 (Coleman et al., , 2000 , and these are induced in the livers of alachlor-treated mice. Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as a loading control for liver samples. TOXICOLOGIC PATHOLOGY (Salonpaa et al., 1994; Kojo et al., 1998; Gilmore and Kirby, 2004) , CYP2A5 levels were not increased in C57BL/6J mouse liver following chronic alachlor treatment. We also evaluated levels of 2 cytochrome P450 proteins implicated in alachlor metabolism in humans, namely CYP3A4 and CYP2B6, using antibodies that recognize the murine proteins. Western blots using CYP3A1/2 and 2B1/2 antisera suggest a modest increase in these proteins in the livers of C57BL/6J mice treated with alachlor for 14 months. These observations are in contrast to those previously reported in rat liver, which showed no enzyme induction (Wetmore et al., 1999) .
The distribution of CYP2A5 in the mouse nasal cavity is different from that previously reported for CYP2A3 in the rat (Genter et al., 2000) . In the mouse, CYP2A5 immunoreactivity is most intense along the dorsal nasal septum and in the mucosa lining the dorsal medial meatus (Figure 3) . The pattern of staining in rat nasal cavity sections (Figure 3 ) was identical (but weaker) to that seen with the anti-CYP2A10/2A11 antibody used in our previous studies (Genter et al., 2000) . β-catenin immunoreactivity was undetectable in the olfactory mucosa of any of the mouse strains (as was the case with untreated rats (Genter et al., 2002b) ), and did not change with alachlor treatment.
Finally, we asked whether the olfactory neurons in which eosinophilic inclusions had accumulated in alachlortreated mice were immunopositive for olfactory marker protein (OMP), which distinguishes mature, functional olfactory neurons (Kream and Margolis, 1984) . Neurons with eosinophilic inclusions were no longer immunoreactive with the OMP antibody, in contrast to adjacent, uninvolved olfactory neurons (Figure 4) . These data suggest that neuronal differentiation may be perturbed in the olfactory mucosa by alachlor exposure.
DISCUSSION
The results of the current study, together with previous work in the rat (Genter et al., 2000 (Genter et al., , 2002a (Genter et al., , 2002b confirm that there is a marked species difference in response to alachlor between rats and mice. Rats treated chronically with alachlor (126 mg/kg/d) developed treatment-related olfactory tumors with ≥5 months of treatment. The progression of these tumors to more malignant phenotypes was accompanied by cytoplasmic accumulation and nuclear localization of β-catenin, and an observation that is suggestive of activation of Wnt signaling (U.S. EPA, 1985; Genter et al., 2000 Genter et al., , 2002a Genter et al., , 2002b . In contrast, in the present study, we found no neoplastic changes in any of the 3 strains examined (treated at a higher dose of 260 mg/kg/d). A previous study in CD-1 mice, an outbred strain, was negative for alachlor-induced olfactory tumors (U.S. EPA 1985) . However, we hypothesized that Apc Min/+ mice would be susceptible to alachlor-induced olfactory carcinogenesis because they have activated Wnt signaling due to mutation of the second allele of Apc. We also examined 2 inbred strains of mice that are commonly used in respiratory toxicology studies (C57BL/6J and A/J) to determine whether resistance to alachlor-induced olfactory carcinogenesis is a response common to multiple mouse strains. We found that these, too, were resistant, even with >1 year of exposure (260 mg/kg/d) in the C57BL/6J mice. At the same time point, 14 of 15 alachlor-treated (126 mg/kg/d) rats had 1 or more olfactory neoplasms (Genter et al., 2002a) .
Alachlor-treated mice were not without treatment-related lesions. Apc Min/+ mice, and their wild-type littermates, infrequently displayed any histological changes. When changes did occur in these mice, the lesions most often occurred at the base of the nasal septum and generally consisted of hyperplasia of the Bowman's glands, abnormal appearance of the olfactory epithelium (e.g., cells migrating horizontally across the surface of the epithelium), and/or a small number of cells with glassy eosinophilic inclusions (e.g., Figure 1D) . A/J mice (treated for 10.5 months) and C57BL/6J mice (treated for 14 months) did not have lesions at the base of the septum. Rather, both of these mouse strains displayed mucous cell hyperplasia (most often occurring at the junction of the respiratory and olfactory epithelia on the nasal septum) and extensive accumulation of glassy, eosinophilic inclusions in the neuroepithelial cells. The latter lesion was found most often on the 2 ectoturbinate. In addition, we found that OMP immunoreactivity was greatly reduced or abolished in regions of the olfactory mucosa containing eosinophilic inclusions, suggesting that the accumulation of this material could reduce olfactory function.
There are a number of possible explanations for the difference in response between rats and mice. If CYP2A levels in rat olfactory mucosa were higher than mouse, then the rat olfactory mucosa could be more capable of bioactivation of alachlor to a mutagenic metabolite than the mouse olfactory mucosa. Protein analysis of CYP2A levels, however, suggests that this is not the case. Alachlor may induce enzymes involved in its metabolism in mouse liver more readily than in the rat, resulting in greater excretion and lower levels of circulating metabolites. Our data demonstrate induction of CYPs 3A1/2 and 2B1/2 in the mouse liver following alachlor treatment, while our previous studies demonstrate that enzyme induction does not occur in rat liver (Wetmore et al., 1999) . Other explanations may be a lower affinity for alachlor or alachlor metabolites by mouse CYP2A5 vs. rat CYP2A3, greater absorption of alachlor in rat vs. mouse, or different responses of target tissue to alachlor or alachlor metabolites. These areas will be the subject of future investigations.
We previously described the distribution of rat CYP2A3 in control rat nasal tissues (Genter et al., 2000) . CYP2A3 is immunolocalized in the lateral and ventral regions of the rat nasal cavity, but is not detected along the nasal septum (except at the very ventral tip adjacent to the nasopharynx) or in the mucosa lining the major route of airflow in the nasal cavity, the dorsal medial meatus (Kimbell et al., 1993) . The distribution of rat CYP2A3 colocalized precisely with the distribution of tumors in alachlor-treated rats, leading to the hypothesis that CYP2A3 is the enzyme in the rat nasal cavity responsible for bioactivation of alachlor (or a circulating metabolite) to a mutagenic and carcinogenic species. The significance of the difference in distribution of CYP2A between rats and mice is not clear, but suggests that mouse CYP2A5 participates in the metabolism of inhaled xenobiotics, while rat CYP2A3 does not. There is a high degree, but not complete overlap, of substrate specificity for rat, mouse, and human CYP2A proteins (Fernandez-Salguero and Gonzalez, 1995; Raunio Vol. 32, No. 6, 2004 MURINE OLFACTORY RESPONSES TO ALACHLOR 723 FIGURE 3.-Immunohistochemistry detects CYP2A5 and 2A3 in the A/J mouse and Long-Evans rat nasal cavity, respectively. (A) Positive immunoreactivity in the mouse nasal cavity is present along the dorsal septum (S) and the medial aspect of several turbinates (t), but absent from the ventral septum, lateral aspect of turbinates, and the lateral wall (arrows) (×10). This distribution is very different from that of CYP2A3 in the rat nasal cavity (B), where immunoreactivity is present in the lateral regions of the nasal cavity (boxes), but absent from the dorsal septums and the mucosa lining the dorsal medial meatus (S) (×4). Turbinate numbering scheme (Arabic numbers) was described by Young (1981) . C. High magnification photomicrograph, showing CYP2A localization primarily in the Bowman's glands (BG) and apical cytoplasm of sustentacular cells (SUS) (×40). Lewis and Lake, 2002) . Additionally, CYP2A isoforms have very specific tissue distributions, including olfactory mucosa, esophagus, lung and liver (Gopalakrishnan et al., 1999) .
It has been previously noted that the rat olfactory mucosa appears to be more susceptible to toxicant-induced degeneration and carcinogenesis than the mouse. For example, methylated DNA bases and nasal tumors develop in rats, but not mice, exposed to the tobacco-specific nitrosamine NNK (4-(methylnitrosamino)-1-(3-pyridyl)-1butanone) (Van Benthem et al., 1994) . Olfactory mucosal FIGURE 4.-Immunohistochemistry detects olfactory marker protein (OMP) in a turbinate with eosinophilic inclusions (alachlor-treated A/J mouse). (A) Section of a turbinate stained with hematoxylin and eosin (×20). (B) Section of turbinate from alachlor-treated A/J mouse in which mature olfactory neurons are identified by a red aminoethylcarbazole reaction product that shows OMP. Areas of the mucosa occupied by eosinophilic material are void of mature olfactory neurons. Several positive neurons are indicated (arrows) (×20). Debris in the nasal airway shows nonspecific immunoreactivity, and subepithelial staining is due to peroxidase activity of red blood cells in blood vessels (BV). toxicity and carcinogenicity occur in rats treated with the phosphodiesterase inhibitor RP 73401, but not mice or dogs (Pino et al., 1999) . Similarly, naphthalene is carcinogenic in the rat olfactory mucosa, but not the mouse (National Toxicology Program, 1992; Long et al., 2003) . Coumarin caused olfactory mucosal degeneration in both rats and mice; however, rats were more sensitive than mice. The difference in response to coumarin was not attributable to differences in olfactory mucosal metabolism, which was equivalent in rats in mice, but rather was attributed to greater coumarin bioactivation in the liver of the rat (Zhuo et al., 1999) . Approximately 724 GENTER ET AL.
TOXICOLOGIC PATHOLOGY twice the dose of diethyldithiocarbamate was required to cause olfactory degeneration in mice than rats. In this case, the enhanced sensitivity of rats was attributed to 2-fold higher levels of CYP2E1 activity in rat olfactory mucosa than mice (Deamer and Genter, 1995) . Exceptions to the trend described above have been observed in a few instances. For example, mice are far more sensitive to olfactory cytotoxic damage following exposure to styrene than rats (Cruzan et al., 1999; Green et al., 2001) . O-nitrotoluene caused tissue lesions and tumors at multiple sites, but not the olfactory mucosa, in rats, while the only lesion found in mice exposed to 625-10,000 ppm of o-nitrotoluene for 13-weeks was a dose-related increase in olfactory mucosal degeneration (Dunnick et al., 1994) .
From the findings of the current studies, as well as other examples cited, it is clear that both pharmacokinetic parameters and local tissue metabolism are important in the ultimate distribution of lesions resulting from both inhaled and systemically administered toxicants. An understanding of the differences in response between rats and mice, as well as extrapolation of findings in rodents to human responses is important, given the putative link between olfactory mucosal chemical uptake from the nasal cavity into the brain and the development of various neurodegenerative diseases (Takeda et al., 1998; Sunderman, 2001; Hawkes, 2003) .
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